Experience

Brent Siler

    • Passage Bio - $216 Million IPO 


    • argenx – $557 Million Follow-On Offering 


    • SpringWorks Therapeutics – $186 Million IPO  


    • Karuna Therapeutics $103 million IPO 


    • NextCure – $86 Million IPO 


    • Stealth BioTherapeutics $78 Million IPO 


    • LogicBio Therapeutics – $80.5 Million IPO 


    • Entasis Therapeutics – $75 Million IPO 


    • MeiraGTx – $75 Million IPO 


    • Verrica Pharmaceuticals – $86 Million IPO 


    • Cooley Advises on Nightstar + NuCana IPOs 


    • Verona – $80 Million IPO 


    • Advaxis – $30 Million Registered Direct Offering 


    • Recro Pharma – $15 Million Follow-On  


    • Strongbridge Biopharma IPO 


    • Aclaris Therapeutics IPO 


    • Chiasma Completes $117 Million IPO 


    • Catabasis Completes $69 Million IPO 


    • KemPharm Completes its IPO 


    • Vascular Biogenics Prices IPO 


    • Cooley's Capital Markets Leadership Continues through 1H 2014 


    • T2 Biosystems IPO 


    • 2U $119 Million Initial Public Offering 


    • Egalet Corporation IPO 


    • Eleven Biotherapeutics IPO 


    • Trevena $64 Million Initial Public Offering 


    • First US IPO of 2014 for GlycoMimetics 


    • TetraLogic Initial Public Offering 


    • Millennial Media Acquisition of Jumptap 


    • Onconova Therapeutics IPO 


    • Epizyme, Inc. Initial Public Offering